Iceland - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes
Since 2014, Iceland Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes grew 4.1% year on year. In 2019, the country was number 16 comparing other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes at €208.16 Per Capita. Iceland is overtaken by Netherlands, which was number 15 at €224.53 Per Capita and is followed by Slovakia with €196.26 Per Capita. Switzerland lead the ranking with €666.37 Per Capita in 2019, an increase of 3.2% compared to 2018. Germany, Liechtenstein and Ireland respectively ranked number 2, 3 and 4 in this ranking. Latvia witnessed the best average annual growth at +8.8% per year, while Romania was the worst growing country at -1.7% per year.
Loading...
| Date | Euros Per Capita |
|---|---|
| 2019 | 208.16 |
| 2018 | 207.75 |
| 2017 | 204.27 |
| 2016 | 191.93 |
| 2015 | 181.85 |
How does Iceland rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes?
| # | 33 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Switzerland
|
666.37 | 2019 | +3.1 % | +5.3 % | View data | |
| 2 |
#2
Germany
|
553.39 | 2019 | +2.3 % | +3.0 % | View data | |
| 15 |
#15
Netherlands
|
224.53 | 2019 | -0.6 % | +0.7 % | View data | |
| 16 |
#16
Iceland
|
208.16 | 2019 | +0.2 % | +4.1 % | View data | |
| 17 |
#17
Slovakia
|
196.26 | 2019 | +0.8 % | +0.9 % | View data | |